Pharmacologic treatment of exercise-induced asthma

Exercise-induced asthma (EIA) is a complex disorder affecting a sizeable minority of athletes. Proper pharmacologic management allows most every athlete at any level to participate with EIA. This article briefly addresses the pathophysiology, diagnosis, and basic treatment principles, including nonpharmacologic management for EIA. Most of the article details the current treatment strategies and provides information on experimental treatments being investigated. In addition, ergogenic concerns and problems in treating elite athletes are discussed.